Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.
每年筛查微量白蛋白尿将有助于在肾病病程的极早期识别出患者。改善血糖控制、积极进行抗高血压治疗以及使用血管紧张素转换酶抑制剂将减缓肾病的进展速度。此外，蛋白质限制及其他治疗方式（如降低磷酸盐）可能对部分患者有益。
